BAXTER INTERNATIONAL INC — Director's Dealing 2012

Aug 10, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: KALOBIOS PHARMACEUTICALS INC (NONE)
CIK: 0001293310
Period of Report: 2012-08-11

Reporting Person: BAXTER INTERNATIONAL INC (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series D Preferred Stock	$		Common Stock (3000308)		Direct

Footnotes

F1: Each share of Preferred Stock is convertible at any time, at the election of the holder, into one fully paid and nonassessable share of Common Stock, subject to certain anti-dilution adjustments.

F2: No expiration date.